Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Xiaowen Zhang, Yang Fan & Zhijie Li. (2017) SDF1-3′A polymorphism is associated with increased risk of hematological malignancy: a meta-analysis. OncoTargets and Therapy 10, pages 1575-1583.
Read now
Read now
Kaspar Rene Nielsen, Rudi Steffensen, Thure Mors Haunstrup, Julie Støve Bødker, Karen Dybkær, John Baech, Martin Bøgsted & Hans Erik Johnsen. (2015) Inherited variation in immune response genes in follicular lymphoma and diffuse large B-cell lymphoma. Leukemia & Lymphoma 56:12, pages 3257-3266.
Read now
Read now
Young Ho Lee & Gwan Gyu Song. (2015) Association between chemokine receptor 5 delta32 polymorphism and susceptibility to cancer: a meta-analysis. Journal of Receptors and Signal Transduction 35:6, pages 509-515.
Read now
Read now
Kenji Maeda, Debananda Das, Hirotomo Nakata & Hiroaki Mitsuya. (2012) CCR5 inhibitors: emergence, success, and challenges. Expert Opinion on Emerging Drugs 17:2, pages 135-145.
Read now
Read now
Articles from other publishers (15)
Xue-Jiao Lu, Lin Li & Xin-Ying Zhou. (2023) Effect of CCR2-V64I on the Susceptibility of Patients to Cancer. European Journal of Cancer Care 2023, pages 1-10.
Crossref
Crossref
Tabish Qidwai & M.Y. Khan. (2016) Impact of genetic variations in C-C chemokine receptors and ligands on infectious diseases. Human Immunology 77:10, pages 961-971.
Crossref
Crossref
Tabish Qidwai. (2016) Chemokine genetic polymorphism in human health and disease. Immunology Letters 176, pages 128-138.
Crossref
Crossref
Xiang Tong, Yao Ma, Huajiang Deng, Xixi Wang, Sitong Liu, Zhipeng Yan, Shifeng Peng & Hong Fan. (2016) The SDF-1 rs1801157 Polymorphism is Associated with Cancer Risk: An Update Pooled Analysis and FPRP Test of 17,876 Participants. Scientific Reports 6:1.
Crossref
Crossref
Dan Meng, Yin-xiang Wu, Vidhi Heerah, Shuang Peng, Meng-di Chu, Yong-jian Xu, Wei-ning Xiong & Shu-yun Xu. (2015) CXCL12 G801A polymorphism and cancer risk: An updated meta-analysis. Journal of Huazhong University of Science and Technology [Medical Sciences] 35:3, pages 319-326.
Crossref
Crossref
Houqun Ying, Jie Wang & Xueren Gao. (2014) CCL5-403, CCR5-59029, and Delta32 polymorphisms and cancer risk: a meta-analysis based on 20,625 subjects. Tumor Biology 35:6, pages 5895-5904.
Crossref
Crossref
Chi Young Ok, Ling Li, Zijun Y. Xu-Monette, Carlo Visco, Alexander Tzankov, Ganiraju C. Manyam, Santiago Montes-Moreno, Karen Dybaer, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Jiayu Chen, Kristy L. Richards, Eric D. Hsi, William W. L. Choi, J. Han van Krieken, Jooryung Huh, Weiyun Ai, Maurilio Ponzoni, Andrés J.M. Ferreri, John P. Farnen, Michael B. Møller, Carlo E. Bueso-Ramos, Roberto N. Miranda, Jane N. Winter, Miguel A. Piris, L. Jeffrey Medeiros & Ken H. Young. (2014)
Prevalence and Clinical Implications of Epstein–Barr Virus Infection in
De Novo
Diffuse Large B-Cell Lymphoma in Western Countries
. Clinical Cancer Research 20:9, pages 2338-2349.
Crossref
Crossref
Young Ae Cho & Jeongseon Kim. (2013) Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of cancer: A meta-analysis. Cytokine 64:1, pages 213-220.
Crossref
Crossref
Yuyun Huang, Huilong Chen, Jianmiao Wang, Hansvin Bunjhoo, Weining Xiong, Yongjian Xu & Jianping Zhao. (2013) Relationship between CCR2-V64I polymorphism and cancer risk: A meta-analysis. Gene 524:1, pages 54-58.
Crossref
Crossref
Dongsheng Tang. (2013) CXC chemokine ligand 16, inversely correlated with CD99 expression in Hodgkin Reed-Sternberg cells, is widely expressed in diverse types of lymphomas. Oncology Reports.
Crossref
Crossref
LaCreis R Kidd, Dominique Z Jones, Erica N Rogers, Nayla C Kidd, Sydney Beache, James E Rudd, Camille Ragin, Maria Jackson, Norma McFarlane-Anderson, Marshall Tulloch-Reid, Seian Morrison, Guy N Brock, Shirish S Barve & Kevin S Kimbro. (2012) Chemokine Ligand 5 (CCL5) and chemokine receptor (CCR5) genetic variants and prostate cancer risk among men of African Descent:a case-control study. Hereditary Cancer in Clinical Practice 10:1.
Crossref
Crossref
Sara Raimondi, Sara Gandini, Maria Concetta Fargnoli, Vincenzo Bagnardi, Patrick Maisonneuve, Claudia Specchia, Rajiv Kumar, Eduardo Nagore, Jiali Han, Johan Hansson, Peter A Kanetsky, Paola Ghiorzo, Nelleke A Gruis, Terry Dwyer, Leigh Blizzard, Ricardo Fernandez-de-Misa, Wojciech Branicki, Tadeusz Debniak, Niels Morling, Maria Teresa Landi, Giuseppe Palmieri, Gloria Ribas, Alexander Stratigos, Lynn Cornelius, Tomonori Motokawa, Sumiko Anno, Per Helsing, Terence H Wong, Philippe Autier, José C García-Borrón, Julian Little, Julia Newton-Bishop, Francesco Sera, Fan Liu, Manfred Kayser & Tamar Nijsten. (2012) Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studies. BMC Medical Research Methodology 12:1.
Crossref
Crossref
A. Al-Qahtani, S. Alarifi, M. Al-Okail, Z. Hussain, A. Abdo, F. Sanai, M. Al-Anazi, N. Khalaf, H. Al-Humaidan, M. Al-Ahdal & F.N. Almajhdi. (2012) RANTES gene polymorphisms (-403G>A and -28C>G) associated with hepatitis B virus infection in a Saudi population. Genetics and Molecular Research 11:2, pages 855-862.
Crossref
Crossref
Richard F Ambinder, Kishor Bhatia, Otoniel Martinez-Maza & Ronald Mitsuyasu. (2010) Cancer biomarkers in HIV patients. Current Opinion in HIV and AIDS 5:6, pages 531-537.
Crossref
Crossref
James T. Elder. (2010) What Can Psoriasis Teach Us About the Genetic Basis of Cutaneous T-Cell Lymphoma?. Clinical Lymphoma Myeloma and Leukemia 10, pages S70-S73.
Crossref
Crossref